Virtual hospital for Alzheimer's disease in the Metaverse
Virtual hospital for Alzheimers' disease is more than a therapy...it is a TOTAL APPROACH...
Precision or personalized THERAPY for Alzheimer's disease...all your records in one place, monitoring to offer advice and support, this virtual service is possible 24/24h...with all kind of tracking data and AI,ML...daily food advice, an exercise program for better balance, more strength, memory, loneliness, isolation
If we have enough data...we can treat Alzheimer's disease...you can't make a diagnosis based on snapshot data like scan data (PET, MRI), lumbar punction or blood samples...we need big data for AI, ML, DL
Different brains give different responses to the same drug...
Different patients respond to the same drug but also to the same therapy in different ways...Today we see a trial-and-error treatment..we diagnose and treat mental disorders the same way as we have for past 50 years...There is no way to know in advance whether any drug will work for an individual or not. Try and wait...after more than 400,000 clinical trials there is no treatment for Alzheimer's disease...
Precision therapy for Alzheimer's disease is a combination of the right drugs for the right patient, real-time monitoring, AI-derived brain biomarkers, treated loneliness and isolation, digital therapeutics DTX, genomics and decentralized clinical trials ( data from patients where patients are not from hospitals or study centers)
An Alzheimer's disease patient's digital twin is designed to capture continuous data from the individual about various vitals, medical condition, response to a treatment or drug and surrounding ecosystem. Unique digital twin from each patient help in determining right therapy, predict the outcome of a specific procedure and manage Alzheimer's disease.The Metaverse shouldn't be a replacement for the real world. It should help you augment the real world. It should allow you to do things that maybe were not possible in the physical world.
AR is going to be more common than VR because it doesn't remove you from your physical reality. I can still be present in my physical world and that is important for Alzheimer's patients. We can train disrupted parts of the brain in a home environment...train disrupted neural circuits so that other circuits can take over the disruped function of this specific neural circuit.
St Dimphna - Goswyn van der Weyden 1505
Geel in Belgium, the oldest therapeutic community...
Royal College of Psychiatrists NCBI
Computerised cognitive behavioural therapy ( CBT)
The ability to provide CBT to a larger population is not possible using traditional methods. CBT for Alzheimer's and dementia treatment, as a fully automated, advanced algorithm-driven program being used without any support from a human, offers a sollution to the problem of scalability.
CBT is practiculary appropriate for digitisation, given its structured format, emphasis an active participation and self-monitoring and intrasession "homeworks" requirements. Computerised CBT for Alzheimer's disease has been shown to be an effective treatment with effects comparable to those found for face-to-face therapy.
AI chatbot for dementia and Alzheimer's patients
The robots that caregivers want
Un. of California San Diego
Study Alzheimer's and Dementia robots
- pet-like robots
- cleaning robots
- telepresence robots
- smart speakers
1. Robots to be capable of facial recognition
2. Support positive moments shared by caregivers and their loved ones
3. Lessen caregivers emotional stress by taking on difficult tasks...such as answering repeated questions and restricting healthy food
4.Robots should be able to adopt to new situations ( progression of the disease)
5. Robots should be able to learn from end users and customize and personalize
6. Human-l with ike components not look like humans
7. Interact with human via voice activation
^Personality of our robots are based on the OCEAN personality theory
In 2011, a researcher did a postmortem analysis of 426 Japanese-American residents of Hawaii, about half of whom had been diagnosed with some form of dementia, typically Alzheimer’s. According to the autopsies, roughly half of that group had been misdiagnosed as having Alzheimer’s — their brains didn’t show evidence of the brain lesions typical of the disease. At a 2016 conference, Canadian scientists presented preliminary findings, based on more than 1,000 individuals, that patients were correctly diagnosed only 78 percent of the time. In nearly 11 percent of cases, patients thought to have Alzheimer’s actually didn’t, while another 11 percent did have the disease but weren’t diagnosed.
Accurate diagnosis is needed for Dementia Lewy Body
Dementia with Lewy Bodies (DLB) may account for up to 30% of all dementia cases. The symptoms of DBL can be difficult to disentangle from other dementia subtypes. DLB is characterized by a build-up of abnormal proteins (Lewy bodies) in areas that control cognition, movement, allertness and behavior.
Eye tracking ( saccadic eye movement tracking) and EEG are very sensitive digital biomarkers to make an accurate diagnosis.
AD and DLB pathologies often overlap within individuals. An individual is diagnosed with Parkinson disease dementia ( PDD) or DLB depends on the timing of symptoms onset. In dementia with Lewy Bodies, cognitive decline occurs within one year of the onset of movement disorder symptoms.
DLB is sensivity to antipsychotic drugs. We see also REM behavior disorder. Visual hallucinations and fluctuations in cognition, attention and allertness.
Mild Cognitive Impairment or MCI
MCI causes a slight but noticeable and measurable decline in cognitive abilities, including memory and thinking skills. Long-term studies suggest that 15-20 percent of the aged 65 and older may have MCI. There is a difference between normal aging cognitive decline and MCI. With all kind of rating scales it is not possible to see any difference.
Biomarkers for Alzheimer's disease can be really measured to indicate the presence or absense of the disease. For AD there is only one biomarker accepted amyloid beta. Preclinical b. amyloid as biomarker is difficult and very expensive to detect and it is only possible in hospitals. Digital biomarkers can be used outside the hospital POC ( in the waiting room or at home).
Blood glucose levels are a biomarker for diabetes and blood cholesterol for heart disease.
These are the most commonly misdiagnosed conditions.
It is a degenerative disorder of the central nervous system with symptoms including tremors in hands, arms or legs, stiff muscles, and problems with balance or walking.
However, it is commonly mistaken for Alzheimer’s disease, stroke, stress, a traumatic head injury and essential tremor.
The condition causes an overactive thyroid gland, and is the most common cause of hyperthyroidism.
Symptoms include eyes bulging, anxiety, sweating, rapid pulse, unplanned weight loss or gain, and extreme tiredness.
Without treatment, it can prove life-threatening, however it is often mistaken for depression, ageing and under-exercising.
It is a chronic arthritis-like disorder characterised by widespread pain.
However, symptoms - anxiety, sensitivity to pain and incapacitating fatigue - can be confused with rheumatoid arthritis and chronic fatigue syndrome.
Normal pressure hydrocephalus
It is a build-up of cerebrospinal fluid in the brain that most commonly occurs after a stroke or ahead injury from a fall.
Symptoms of unsteady gait, progressive dementia and urinary problems, can be interpreted as Alzheimer’s disease or Parkinson’s disease.
The progressive autoimmune disease that attacks the central nervous system has symptoms including muscle spasms, lack of coordination, balance problems, blurred vision and cognitive impairment.
However, it is commonly mistaken for a viral infection, lupus, Alzheimer’s disease and bipolar disorder.
It is an autoimmune disorder marked by an inability to digest gluten, a protein in wheat, rye and barley.
Symptoms can include vomiting, abdominal pain and bloating, diarrhoea, weight loss, anaemia and leg cramps.
However it can be mistaken for irritable bowel syndrome, Crohn’s disease and cystic fibrosis
Chronic fatigue syndrome
The complex disorder has no known cause but symptoms include loss of memory or concentration, a sore throat, painful lymph nodes in neck or armpits, unexplained muscle or joint pain and extreme exhaustion.
It is often confused with sinus problems, hepatitis, fibromyalgia, lupus and rheumatoid arthritis.
It is a chronic inflammatory disease, with symptoms including fatigue, kidney, heart and lung damage, rash and joint pain.
However, it can be mistaken for chronic fatigue syndrome, fibromyalgia and rheumatoid arthritis.
This is where a tear develops in the aorta, the largest blood vessel branching from the heart, which causes the inner and middle layers to separate.
Symptoms can include sudden chest or upper back pain, loss of consciousness, shortness of breath, sweating and weak pulse in one arm.
However it can be misdiagnosed as heartburn, heart attack and stroke.